Guardant Health
374 hedge funds and large institutions have $11.8B invested in Guardant Health in 2021 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 136 increasing their positions, 124 reducing their positions, and 71 closing their positions.
20% more call options, than puts
Call options by funds: $94.2M | Put options by funds: $78.2M
6% more capital invested
Capital invested by funds: $11.1B → $11.8B (+$641M)
4.33% more ownership
Funds ownership: 88.6% → 92.94% (+4.3%)
10% more repeat investments, than reductions
Existing positions increased: 136 | Existing positions reduced: 124
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
10% less funds holding
Funds holding: 417 → 374 (-43)
55% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 71
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$372M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$187M |
| 3 |
Morgan Stanley
New York
|
+$156M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$92.1M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
+$75.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSCM
Light Street Capital Management
Palo Alto,
California
|
-$63.6M |
| 2 |
MWNA
Marshall Wace North America
New York
|
-$60.7M |
| 3 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$54.3M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$41.8M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$34.4M |
GH Hedge Fund Activity: Q3 2021 in Review
374 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q3 2021, worth a combined $11.8B — up 5.8% from $11.1B a quarter earlier.
Sellers outnumbered buyers: 71 funds closed out of GH and 32 opened new positions — a net loss of 39 holders — while 124 trimmed existing stakes and 136 added.
The largest buyer was Capital Research Global Investors, adding an estimated $372M. The largest seller was Light Street Capital Management, exiting entirely with an estimated $63.6M sold.
- 374 institutional investors held Guardant Health (GH) as of Q3 2021, down from 417 in Q2 2021.
- Funds reported $11.8B of Guardant Health stock for Q3 2021, up 5.8% quarter-over-quarter.
- 32 funds opened new Guardant Health positions in Q3 2021 and 71 closed out, a net change of -39 holders.
- The largest Guardant Health buyer in Q3 2021 was Capital Research Global Investors, an estimated $372M added.
- The largest Guardant Health seller in Q3 2021 was Light Street Capital Management, an estimated $63.6M sold.
Based on aggregated 13F filings for Q3 2021.